Global Cancer Tissue Diagnostics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Tissue Diagnostics Revenue
1.4 Market Analysis by Type
1.4.1 Global Cancer Tissue Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunohistochemistry (IHC) Test
1.4.3 In Situ Hybridisation Test
1.5 Market by Application
1.5.1 Global Cancer Tissue Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Cancer Tissue Diagnostics Market Perspective (2015-2026)
2.2 Cancer Tissue Diagnostics Growth Trends by Regions
2.2.1 Cancer Tissue Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Tissue Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Tissue Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Cancer Tissue Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Tissue Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tissue Diagnostics Players by Market Size
3.1.1 Global Top Cancer Tissue Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Tissue Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Tissue Diagnostics Market Concentration Ratio
3.2.1 Global Cancer Tissue Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Tissue Diagnostics Revenue in 2019
3.3 Cancer Tissue Diagnostics Key Players Head office and Area Served
3.4 Key Players Cancer Tissue Diagnostics Product Solution and Service
3.5 Date of Enter into Cancer Tissue Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Cancer Tissue Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2021-2026)
5 Cancer Tissue Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Cancer Tissue Diagnostics Market Size by Application (2015-2020)
5.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Tissue Diagnostics Market Size (2015-2020)
6.2 Cancer Tissue Diagnostics Key Players in North America (2019-2020)
6.3 North America Cancer Tissue Diagnostics Market Size by Type (2015-2020)
6.4 North America Cancer Tissue Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Tissue Diagnostics Market Size (2015-2020)
7.2 Cancer Tissue Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Cancer Tissue Diagnostics Market Size by Type (2015-2020)
7.4 Europe Cancer Tissue Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Cancer Tissue Diagnostics Market Size (2015-2020)
8.2 Cancer Tissue Diagnostics Key Players in China (2019-2020)
8.3 China Cancer Tissue Diagnostics Market Size by Type (2015-2020)
8.4 China Cancer Tissue Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Tissue Diagnostics Market Size (2015-2020)
9.2 Cancer Tissue Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Cancer Tissue Diagnostics Market Size by Type (2015-2020)
9.4 Japan Cancer Tissue Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Tissue Diagnostics Market Size (2015-2020)
10.2 Cancer Tissue Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Tissue Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Tissue Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Cancer Tissue Diagnostics Market Size (2015-2020)
11.2 Cancer Tissue Diagnostics Key Players in India (2019-2020)
11.3 India Cancer Tissue Diagnostics Market Size by Type (2015-2020)
11.4 India Cancer Tissue Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Tissue Diagnostics Market Size (2015-2020)
12.2 Cancer Tissue Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Tissue Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Cancer Tissue Diagnostics Market Size by Application (2015-2020)
13Key Players Profiles
13.1 F. Hoffmann-La Roche Ltd.
13.1.1 F. Hoffmann-La Roche Ltd. Company Details
13.1.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.1.3 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Introduction
13.1.4 F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Ltd. Recent Development
13.2 Danaher Corporation
13.2.1 Danaher Corporation Company Details
13.2.2 Danaher Corporation Business Overview and Its Total Revenue
13.2.3 Danaher Corporation Cancer Tissue Diagnostics Introduction
13.2.4 Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.2.5 Danaher Corporation Recent Development
13.3 Thermo Fisher Scientific Inc.
13.3.1 Thermo Fisher Scientific Inc. Company Details
13.3.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
13.3.3 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Introduction
13.3.4 Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.3.5 Thermo Fisher Scientific Inc. Recent Development
13.4 Bio Rad Laboratories Inc.
13.4.1 Bio Rad Laboratories Inc. Company Details
13.4.2 Bio Rad Laboratories Inc. Business Overview and Its Total Revenue
13.4.3 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Introduction
13.4.4 Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.4.5 Bio Rad Laboratories Inc. Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview and Its Total Revenue
13.5.3 Abbott Cancer Tissue Diagnostics Introduction
13.5.4 Abbott Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Enzo Life Sciences, Inc.
13.6.1 Enzo Life Sciences, Inc. Company Details
13.6.2 Enzo Life Sciences, Inc. Business Overview and Its Total Revenue
13.6.3 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Introduction
13.6.4 Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.6.5 Enzo Life Sciences, Inc. Recent Development
13.7 Agilent Technologies, Inc.
13.7.1 Agilent Technologies, Inc. Company Details
13.7.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue
13.7.3 Agilent Technologies, Inc. Cancer Tissue Diagnostics Introduction
13.7.4 Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.7.5 Agilent Technologies, Inc. Recent Development
13.8 Cancer Genetics Inc.
13.8.1 Cancer Genetics Inc. Company Details
13.8.2 Cancer Genetics Inc. Business Overview and Its Total Revenue
13.8.3 Cancer Genetics Inc. Cancer Tissue Diagnostics Introduction
13.8.4 Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.8.5 Cancer Genetics Inc. Recent Development
13.9 Merck KGaA (Sigma-Aldrich Co. LLC)
13.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
13.9.2 Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview and Its Total Revenue
13.9.3 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Introduction
13.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
13.10 Abcam plc.
13.10.1 Abcam plc. Company Details
13.10.2 Abcam plc. Business Overview and Its Total Revenue
13.10.3 Abcam plc. Cancer Tissue Diagnostics Introduction
13.10.4 Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2015-2020)
13.10.5 Abcam plc. Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Cancer Tissue Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Tissue Diagnostics Revenue
Table 3. Ranking of Global Top Cancer Tissue Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Tissue Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunohistochemistry (IHC) Test
Table 6. Key Players of In Situ Hybridisation Test
Table 7. Global Cancer Tissue Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Cancer Tissue Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Cancer Tissue Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Cancer Tissue Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Cancer Tissue Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Cancer Tissue Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cancer Tissue Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Cancer Tissue Diagnostics Players
Table 18. Global Cancer Tissue Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Cancer Tissue Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tissue Diagnostics as of 2019)
Table 21. Global Cancer Tissue Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Tissue Diagnostics Product Solution and Service
Table 24. Date of Enter into Cancer Tissue Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Tissue Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Cancer Tissue Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Cancer Tissue Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Cancer Tissue Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Cancer Tissue Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Cancer Tissue Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Cancer Tissue Diagnostics Market Share (2019-2020)
Table 34. North America Cancer Tissue Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Cancer Tissue Diagnostics Market Share by Type (2015-2020)
Table 36. North America Cancer Tissue Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Cancer Tissue Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Cancer Tissue Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Cancer Tissue Diagnostics Market Share (2019-2020)
Table 40. Europe Cancer Tissue Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Cancer Tissue Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Cancer Tissue Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Cancer Tissue Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Cancer Tissue Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Cancer Tissue Diagnostics Market Share (2019-2020)
Table 46. China Cancer Tissue Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Cancer Tissue Diagnostics Market Share by Type (2015-2020)
Table 48. China Cancer Tissue Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Cancer Tissue Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Cancer Tissue Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Cancer Tissue Diagnostics Market Share (2019-2020)
Table 52. Japan Cancer Tissue Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Cancer Tissue Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Cancer Tissue Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Cancer Tissue Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Cancer Tissue Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Cancer Tissue Diagnostics Market Share (2019-2020)
Table 58. Southeast Asia Cancer Tissue Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Cancer Tissue Diagnostics Market Share by Type (2015-2020)
Table 60. Southeast Asia Cancer Tissue Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Cancer Tissue Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Cancer Tissue Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Cancer Tissue Diagnostics Market Share (2019-2020)
Table 64. India Cancer Tissue Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Cancer Tissue Diagnostics Market Share by Type (2015-2020)
Table 66. India Cancer Tissue Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Cancer Tissue Diagnostics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Cancer Tissue Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Cancer Tissue Diagnostics Market Share (2019-2020)
Table 70. Central & South America Cancer Tissue Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Cancer Tissue Diagnostics Market Share by Type (2015-2020)
Table 72. Central & South America Cancer Tissue Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Cancer Tissue Diagnostics Market Share by Application (2015-2020)
Table 74. F. Hoffmann-La Roche Ltd. Company Details
Table 75. F. Hoffmann-La Roche Ltd. Business Overview
Table 76. F. Hoffmann-La Roche Ltd. Product
Table 77. F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 78. F. Hoffmann-La Roche Ltd. Recent Development
Table 79. Danaher Corporation Company Details
Table 80. Danaher Corporation Business Overview
Table 81. Danaher Corporation Product
Table 82. Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 83. Danaher Corporation Recent Development
Table 84. Thermo Fisher Scientific Inc. Company Details
Table 85. Thermo Fisher Scientific Inc. Business Overview
Table 86. Thermo Fisher Scientific Inc. Product
Table 87. Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 88. Thermo Fisher Scientific Inc. Recent Development
Table 89. Bio Rad Laboratories Inc. Company Details
Table 90. Bio Rad Laboratories Inc. Business Overview
Table 91. Bio Rad Laboratories Inc. Product
Table 92. Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 93. Bio Rad Laboratories Inc. Recent Development
Table 94. Abbott Company Details
Table 95. Abbott Business Overview
Table 96. Abbott Product
Table 97. Abbott Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 98. Abbott Recent Development
Table 99. Enzo Life Sciences, Inc. Company Details
Table 100. Enzo Life Sciences, Inc. Business Overview
Table 101. Enzo Life Sciences, Inc. Product
Table 102. Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 103. Enzo Life Sciences, Inc. Recent Development
Table 104. Agilent Technologies, Inc. Company Details
Table 105. Agilent Technologies, Inc. Business Overview
Table 106. Agilent Technologies, Inc. Product
Table 107. Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 108. Agilent Technologies, Inc. Recent Development
Table 109. Cancer Genetics Inc. Business Overview
Table 110. Cancer Genetics Inc. Product
Table 111. Cancer Genetics Inc. Company Details
Table 112. Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 113. Cancer Genetics Inc. Recent Development
Table 114. Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
Table 115. Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
Table 116. Merck KGaA (Sigma-Aldrich Co. LLC) Product
Table 117. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 118. Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
Table 119. Abcam plc. Company Details
Table 120. Abcam plc. Business Overview
Table 121. Abcam plc. Product
Table 122. Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2015-2020) (Million US$)
Table 123. Abcam plc. Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Cancer Tissue Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Immunohistochemistry (IHC) Test Features
Figure 3. In Situ Hybridisation Test Features
Figure 4. Global Cancer Tissue Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Cancer Tissue Diagnostics Report Years Considered
Figure 9. Global Cancer Tissue Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Cancer Tissue Diagnostics Market Share by Regions: 2020 VS 2026
Figure 11. Global Cancer Tissue Diagnostics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Cancer Tissue Diagnostics Market Share by Players in 2019
Figure 14. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tissue Diagnostics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Cancer Tissue Diagnostics Revenue in 2019
Figure 16. North America Cancer Tissue Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Cancer Tissue Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Cancer Tissue Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Cancer Tissue Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Cancer Tissue Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Cancer Tissue Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Cancer Tissue Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 25. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Danaher Corporation Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 27. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 29. Bio Rad Laboratories Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bio Rad Laboratories Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 31. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Abbott Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 33. Enzo Life Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Enzo Life Sciences, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 35. Agilent Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 37. Cancer Genetics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Cancer Genetics Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 39. Merck KGaA (Sigma-Aldrich Co. LLC) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 41. Abcam plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Abcam plc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed